Security key
92511W207
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA)
CUSIP: 92511W207
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 8,810,762
- Total 13F shares
- 2,468,945
- Share change
- +2,274,817
- Total reported value
- $10,583,119
- Price per share
- $4.31
- Number of holders
- 31
- Value change
- +$10,479,755
- Number of buys
- 30
- Number of sells
- 4
Report period
Q3 2025
Institutions
31
Top holders
10
VRCA full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Verrica Pharmaceuticals Inc. SEC filings
Verrica Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92511W207
Recent filing periods:
Top shareholders of VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Caligan Partners LP |
13D/G
13F
|
Company |
10%
|
15,856,653
|
$7,769,760 | $0 | 31 Dec 2024 | |
| ARMISTICE CAPITAL, LLC |
13D/G
13F
|
Company |
10%
|
9,235,571
|
$7,480,813 | +$81,611 | 31 Mar 2025 | |
| PERCEPTIVE ADVISORS LLC |
3/4/5
13D/G
|
10%+ Owner |
1.6%
from 13D/G
|
7,099,182
|
$51,398,078 | — | 27 Dec 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.3%
|
2,168,310
|
$1,149,205 | — | 30 Jun 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.4%
|
123,953
|
$65,696 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.98%
|
907,076
|
$480,841 | — | 30 Jun 2025 | |
| Sovran Advisors, LLC |
13F
|
Company |
0.81%
|
750,391
|
$646,087 | — | 30 Jun 2025 | |
| BECK MACK & OLIVER LLC |
13F
|
Company |
0.79%
|
70,000
|
$37,107 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.7%
|
646,156
|
$342,555 | — | 30 Jun 2025 | |
| Mariner, LLC |
13F
|
Company |
0.29%
|
265,295
|
$140,633 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.22%
|
207,402
|
$109,944 | — | 30 Jun 2025 | |
| Y-Intercept (Hong Kong) Ltd |
13F
|
Company |
0.2%
|
186,955
|
$99,105 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.19%
|
175,284
|
$92,918 | — | 30 Jun 2025 | |
| BML Capital Management, LLC |
13F
|
Company |
0.19%
|
174,651
|
$92,583 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.1%
|
91,816
|
$48,672 | — | 30 Jun 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.09%
|
87,293
|
$46,274 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.09%
|
87,200
|
$46,225 | — | 30 Jun 2025 | |
| SteelPeak Wealth, LLC |
13F
|
Company |
0.08%
|
76,000
|
$40,288 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.08%
|
72,730
|
$38,547 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.07%
|
68,660
|
$36,397 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.07%
|
66,585
|
$35,297 | — | 30 Jun 2025 | |
| Composition Wealth, LLC |
13F
|
Company |
0.06%
|
59,769
|
$31,684 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.06%
|
56,470
|
$29,935 | — | 30 Jun 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.06%
|
52,955
|
$28,071 | — | 30 Jun 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.05%
|
50,272
|
$26,650 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
0.04%
|
39,136
|
$20,746 | — | 30 Jun 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.04%
|
38,330
|
$20,319 | — | 30 Jun 2025 | |
| SPC Financial, Inc. |
13F
|
Company |
0.03%
|
30,000
|
$15,903 | — | 30 Jun 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.03%
|
26,886
|
$14,252 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
26,266
|
$13,923 | — | 30 Jun 2025 | |
| Capital Analysts, LLC |
13F
|
Company |
0.02%
|
21,300
|
$11,000 | — | 30 Jun 2025 | |
| Dynamic Technology Lab Private Ltd |
13F
|
Company |
0.02%
|
20,300
|
$11,000 | — | 30 Jun 2025 | |
| Creative Planning |
13F
|
Company |
0.02%
|
19,083
|
$10,116 | — | 30 Jun 2025 | |
| Point72 Asia (Singapore) Pte. Ltd. |
13F
|
Company |
0.01%
|
13,721
|
$7,273 | — | 30 Jun 2025 | |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC |
13F
|
Company |
0.01%
|
11,566
|
$8,174 | — | 30 Jun 2025 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.01%
|
11,500
|
$6,000 | — | 30 Jun 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.01%
|
11,063
|
$5,864 | — | 30 Jun 2025 | |
| Key FInancial Inc |
13F
|
Company |
0.01%
|
9,415
|
$4,991 | — | 30 Jun 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.01%
|
8,400
|
$4,453 | — | 30 Jun 2025 | |
| Legacy Trust |
13F
|
Company |
0.01%
|
6,500
|
$3,446 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
4,987
|
$3,000 | — | 30 Jun 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
4,928
|
$2,612 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
4,143
|
$2,196 | — | 30 Jun 2025 | |
| CWM, LLC |
13F
|
Company |
0%
|
3,624
|
$2,000 | — | 30 Jun 2025 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
3,404
|
$1,805 | — | 30 Jun 2025 | |
| Salomon & Ludwin, LLC |
13F
|
Company |
0%
|
2,900
|
$1,880 | — | 30 Jun 2025 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0%
|
1,957
|
$1,038 | — | 30 Jun 2025 | |
| NISA INVESTMENT ADVISORS, LLC |
13F
|
Company |
0%
|
1,431
|
$759 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
1,379
|
$731 | — | 30 Jun 2025 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0%
|
1,031
|
$547 | — | 30 Jun 2025 |
Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q3 2025
As of 30 Sep 2025,
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,468,945 shares.
The largest 10 holders included
Caligan Partners LP, ARMISTICE CAPITAL, LLC, BOOTHBAY FUND MANAGEMENT, LLC, VANGUARD GROUP INC, Sovran Advisors, LLC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, RENAISSANCE TECHNOLOGIES LLC, and Mariner, LLC.
This page lists
31
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
4
Q3 2025 holders
31
Holder diff
27
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.